181 related articles for article (PubMed ID: 22651256)
1. Regulation of small ubiquitin-like modifier-1, nuclear receptor coreceptor, histone deacetylase 3, and peroxisome proliferator-activated receptor-γ in human adipose tissue.
Finlin BS; Bodles-Brakhop AM; Yao-Borengasser A; Zhu B; Starnes CP; McGehee RE; Peterson CA; Kern PA; Rasouli N
Metab Syndr Relat Disord; 2012 Aug; 10(4):312-7. PubMed ID: 22651256
[TBL] [Abstract][Full Text] [Related]
2. Sumoylation of peroxisome proliferator-activated receptor gamma by apoptotic cells prevents lipopolysaccharide-induced NCoR removal from kappaB binding sites mediating transrepression of proinflammatory cytokines.
Jennewein C; Kuhn AM; Schmidt MV; Meilladec-Jullig V; von Knethen A; Gonzalez FJ; Brüne B
J Immunol; 2008 Oct; 181(8):5646-52. PubMed ID: 18832723
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of HDAC3 promotes ligand-independent PPARγ activation by protein acetylation.
Jiang X; Ye X; Guo W; Lu H; Gao Z
J Mol Endocrinol; 2014 Oct; 53(2):191-200. PubMed ID: 24982244
[TBL] [Abstract][Full Text] [Related]
4. The nuclear receptor corepressors NCoR and SMRT decrease peroxisome proliferator-activated receptor gamma transcriptional activity and repress 3T3-L1 adipogenesis.
Yu C; Markan K; Temple KA; Deplewski D; Brady MJ; Cohen RN
J Biol Chem; 2005 Apr; 280(14):13600-5. PubMed ID: 15691842
[TBL] [Abstract][Full Text] [Related]
5. Stearoyl-coenzyme A desaturase 1 gene expression increases after pioglitazone treatment and is associated with peroxisomal proliferator-activated receptor-gamma responsiveness.
Yao-Borengasser A; Rassouli N; Varma V; Bodles AM; Rasouli N; Unal R; Phanavanh B; Ranganathan G; McGehee RE; Kern PA
J Clin Endocrinol Metab; 2008 Nov; 93(11):4431-9. PubMed ID: 18697866
[TBL] [Abstract][Full Text] [Related]
6. Adipocyte NCoR knockout decreases PPARγ phosphorylation and enhances PPARγ activity and insulin sensitivity.
Li P; Fan W; Xu J; Lu M; Yamamoto H; Auwerx J; Sears DD; Talukdar S; Oh D; Chen A; Bandyopadhyay G; Scadeng M; Ofrecio JM; Nalbandian S; Olefsky JM
Cell; 2011 Nov; 147(4):815-26. PubMed ID: 22078880
[TBL] [Abstract][Full Text] [Related]
7. A SUMOylation-dependent pathway mediates transrepression of inflammatory response genes by PPAR-gamma.
Pascual G; Fong AL; Ogawa S; Gamliel A; Li AC; Perissi V; Rose DW; Willson TM; Rosenfeld MG; Glass CK
Nature; 2005 Sep; 437(7059):759-63. PubMed ID: 16127449
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of glyceroneogenesis by histone deacetylase 3 contributes to lipodystrophy in mice with adipose tissue inflammation.
Zhang J; Henagan TM; Gao Z; Ye J
Endocrinology; 2011 May; 152(5):1829-38. PubMed ID: 21406501
[TBL] [Abstract][Full Text] [Related]
9. Effect of Salusin-β on Peroxisome Proliferator-Activated Receptor Gamma Gene Expression in Vascular Smooth Muscle Cells and its Possible Mechanism.
Xu X; He M; Liu T; Zeng Y; Zhang W
Cell Physiol Biochem; 2015; 36(6):2466-79. PubMed ID: 26279448
[TBL] [Abstract][Full Text] [Related]
10. The optimal corepressor function of nuclear receptor corepressor (NCoR) for peroxisome proliferator-activated receptor γ requires G protein pathway suppressor 2.
Guo C; Li Y; Gow CH; Wong M; Zha J; Yan C; Liu H; Wang Y; Burris TP; Zhang J
J Biol Chem; 2015 Feb; 290(6):3666-79. PubMed ID: 25519902
[TBL] [Abstract][Full Text] [Related]
11. Improved insulin sensitivity after treatment with PPARγ and PPARα ligands is mediated by genetically modulated transcripts.
Rasouli N; Kern PA; Elbein SC; Sharma NK; Das SK
Pharmacogenet Genomics; 2012 Jul; 22(7):484-97. PubMed ID: 22437669
[TBL] [Abstract][Full Text] [Related]
12. Divergent effects of peroxisome proliferator-activated receptor gamma agonists and tumor necrosis factor alpha on adipocyte ApoE expression.
Yue L; Rasouli N; Ranganathan G; Kern PA; Mazzone T
J Biol Chem; 2004 Nov; 279(46):47626-32. PubMed ID: 15339912
[TBL] [Abstract][Full Text] [Related]
13. G Protein-coupled Receptor 40 (GPR40) and Peroxisome Proliferator-activated Receptor γ (PPARγ): AN INTEGRATED TWO-RECEPTOR SIGNALING PATHWAY.
Wang S; Awad KS; Elinoff JM; Dougherty EJ; Ferreyra GA; Wang JY; Cai R; Sun J; Ptasinska A; Danner RL
J Biol Chem; 2015 Aug; 290(32):19544-57. PubMed ID: 26105050
[TBL] [Abstract][Full Text] [Related]
14. Pioglitazone induces apoptosis of macrophages in human adipose tissue.
Bodles AM; Varma V; Yao-Borengasser A; Phanavanh B; Peterson CA; McGehee RE; Rasouli N; Wabitsch M; Kern PA
J Lipid Res; 2006 Sep; 47(9):2080-8. PubMed ID: 16799131
[TBL] [Abstract][Full Text] [Related]
15. Peroxisome proliferator-activated receptors-α and -γ, and cAMP-mediated pathways, control retinol-binding protein-4 gene expression in brown adipose tissue.
Rosell M; Hondares E; Iwamoto S; Gonzalez FJ; Wabitsch M; Staels B; Olmos Y; Monsalve M; Giralt M; Iglesias R; Villarroya F
Endocrinology; 2012 Mar; 153(3):1162-73. PubMed ID: 22253419
[TBL] [Abstract][Full Text] [Related]
16. SUMO-1 regulates body weight and adipogenesis via PPARγ in male and female mice.
Mikkonen L; Hirvonen J; Jänne OA
Endocrinology; 2013 Feb; 154(2):698-708. PubMed ID: 23270804
[TBL] [Abstract][Full Text] [Related]
17. Peroxisome proliferator-activated receptor gene expression in human tissues. Effects of obesity, weight loss, and regulation by insulin and glucocorticoids.
Vidal-Puig AJ; Considine RV; Jimenez-Liñan M; Werman A; Pories WJ; Caro JF; Flier JS
J Clin Invest; 1997 May; 99(10):2416-22. PubMed ID: 9153284
[TBL] [Abstract][Full Text] [Related]
18. A peroxisome proliferator-activated receptor gamma (PPARgamma)/PPARgamma coactivator 1beta autoregulatory loop in adipocyte mitochondrial function.
Deng T; Sieglaff DH; Zhang A; Lyon CJ; Ayers SD; Cvoro A; Gupte AA; Xia X; Baxter JD; Webb P; Hsueh WA
J Biol Chem; 2011 Sep; 286(35):30723-30731. PubMed ID: 21719705
[TBL] [Abstract][Full Text] [Related]
19. Adipocyte-specific Repression of PPAR-gamma by NCoR Contributes to Scleroderma Skin Fibrosis.
Korman B; Marangoni RG; Lord G; Olefsky J; Tourtellotte W; Varga J
Arthritis Res Ther; 2018 Jul; 20(1):145. PubMed ID: 29996896
[TBL] [Abstract][Full Text] [Related]
20. Restoration of adipose function in obese glucose-tolerant men following pioglitazone treatment is associated with CCAAT enhancer-binding protein β up-regulation.
Powell LA; Crowe P; Kankara C; McPeake J; McCance DR; Young IS; Trimble ER; McGinty A
Clin Sci (Lond); 2012 Aug; 123(3):135-46. PubMed ID: 22309242
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
